Neurochemical diversity of dystrophic neurites in the early and late stages of Alzheimer's disease

Experimental Neurology

Volumn 156, Issue 1, 1999, Pages 100-110

  Dickson, Tracey C ^a   King, Carolyn E ^a   McCormack, Graeme H ^a   Vickers, James C ^a  

^a UNIVERSITY OF TASMANIA   (Australia)

Author keywords

Aging; Alzheimer's disease; Dystrophic neurites; Neurofilaments; Synaptogenesis; Tau; amyloid

Indexed keywords

AMYLOID BETA PROTEIN; CHROMOGRANIN A; TAU PROTEIN;

ADULT; AGED; AGING; ALZHEIMER DISEASE; ARTICLE; CELL STRUCTURE; CYTOSKELETON; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; NERVE SPROUTING; NEUROCHEMISTRY; NEUROFILAMENT; NEUROPATHY; PHOSPHORYLATION; PRIORITY JOURNAL; SYNAPTOGENESIS;

EID: 0033066239     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.1998.7010     Document Type: Article

References (33)

1. Braak H., Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 82:1991;239-259.
2. Benzing W. C., Ikonomovic M. D., Brady D. R., Mufson E. J., Armstrong D. M. Evidence that transmitter containing dystrophic neurites precede paired helical filament and Alz-50 formation within senile plaques in the amygdala of nondemented elderly and patients with Alzheimer's disease. J. Comp. Neurol. 334:1993;176-191.
3. Chambers C. B., Muma N. A. Tau mRNA isoforms following sciatic nerve axotomy with and without regeneration. Mol. Brain Res. 48:1997;115-124.
4. Dickson D., Farlo J., Davies P., Crystal H., Fuld P., Yen S. H. Alzheimer's disease: A double-labelling immunohistochemical study of senile plaques. Am. J. Pathol. 132:1988;86-101.
5. Ditella M., Feiguin F., Morfini G., Caceres A. Microfilament-associated growth component depends upon tau for its intracellular localization. Cell Motil. Cytoskel. 29:1994;117-130.
6. Geddes J. F., Vowles G. H., Robinson S. F. D., Sutcliffes J. C. Neurofibrillary tangles, but not Alzheimer-type pathology, in a young boxer. Neuropathol. Appl. Neurobiol. 22:1996;12-16.
7. Guillery R. W. Some electron microscopical observations of degenerative changes in central nervous synapses. Degeneration Patterns in the Nervous System, Vol. 14, Progress in Brain Research. 1965;Elsevier, Amsterdam. p. 57-73.
8. Hof P. R., Knabe R., Bovier P., Bouras C. Neuropathological observations in a case of autism with self-injury behaviour. Acta Neuropathol. 82:1990;321-326.
9. King C. E., Jacobs I., Dickson T. C., Vickers J. C. Physical damage to rat cortical axons mimics early Alzheimer's neuronal pathology. NeuroReport. 8:1997;1663-1665.
10. Ksiezak-Reding H., Dickson D. W., Davies P., Yen S. H. Recognition of tau epitopes by anti-neurofilament antibodies that bind to Alzheimer neurofibrillary tangles. Proc. Natl. Acad. Sci. USA. 84:1987;3410-3414.
11. Lee V. M. Y., Otvos L., Carden M. J., Hollosi M., Dietzschold B., Lazzarini R. Identification of the major multiphosphorylation site in mammalian neurofilaments. Proc. Natl. Acad. Sci. USA. 85:1988;1998-2002.
12. Leterrier J. F., Liem R. K. H., Mushynski M. L. Interactions between neurofilaments and microtubule-associated proteins: A possible mechanism for intraorganellar bridging. J. Cell Biol. 95:1982;982-986.
13. Mattson M. P., Cheng B., Davis D., Bryant K., Lieberburg I., Rydel R. E. Beta-amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. J. Neurosci. 12:1992;376-389.
14. Mattson M. P., Fu W., Waeg G., Uchida K. 4-Hydroxynonenal, a product of lipid peroxidation, inhibits dephosphorylation of the microtubule-associated protein tau. NeuroReport. 8:1997;2275-2281.
15. Masliah E., Mallory M., Hansen L., Alford M., Deteresa R., Terry R. An antibody against phosphorylated neurofilaments identifies a subset of damaged association axons in Alzheimer's disease. Am. J. Pathol. 142:1993;871-882.
16. Meller D., Schmidt-Kastner R., Eysel U. T. Immunohistochemical studies on neurofilament hypertrophy in degenerating retinal terminals of the olivary pretectal nucleus in the rat. J. Comp. Neurol. 648:1993;162-166.
17. Meller D., Eysel U. T., Schmidt-Kastner R. Transient immunohistochemical labeling of rat retinal axons during Wallerian degeneration by a monoclonal antibody to neurofilaments. Brain Res. 648:1994;162-166.
18. Mirra S. S., Heyman A., McKeel D., Sumi S. M., Crain B. J., Brownlee L. M., Vogel F. S., Hughes J. P., Van Belle B., Berg L. The consortium to establish a registry for Alzheimer's disease (CERAD). Part II. Standardization of the neuropathological assessment of Alzheimer's disease. Neurology. 41:1991;479-486.
19. Morris J. C., Storandt M., McKeel D. W., Rubin E. H., Price J. L., Grant E. A., Berg L. Cerebral amyloid deposition and diffuse plaques in "normal" aging: Evidence from presymptomatic and very mild Alzheimer's disease. Neurology. 46:1996;707-719.
20. Nukina N., Kosik K. S., Selkoe D. J. Recognition of Alzheimer paired helical filaments by monoclonal neurofilament antibodies is due to cross reaction with tau protein. Proc. Natl. Acad. Sci. USA. 84:1987;3415-3419.
21. Roberts G. W., Allsop D., Bruton C. The occult aftermath of boxing. J. Neurol. Neurosurg. Psychiat. 53:1990;373-378.
22. Saunders H. L., Dickson T. C., Vickers J. C. Immunolocalisation of β-amyloid precursor protein to plaque-associated synaptic alterations in the early and late stages of Alzheimer's disease. Alzheimer's Rep. 1:1998;111-119.
23. Smith M. A., Rudnicka-Nawrot M., Richey P. L., Praprotnik D., Mulvihill P., Miller C. A., Sayre L. M., Perry G. Carbonyl-related posttranslational modification of neurofilament protein in the neurofibrillary pathology of Alzheimer's disease. J. Neurochem. 64:1995;2660-2666.
24. Sternberger L. A., Sternberger N. H. Monoclonal antibodies distinguish phosphorylated and nonphosphorylated forms of neurofilamentsin situ. Proc. Natl. Acad. Sci. USA. 80:1983;6126-6130.
25. Su J. H., Cummings B. J., Cotman C. W. Plaque biogenesis in brain aging and Alzheimer's disease. 1. Progressive changes in phosphorylation states of paired helical filaments and neurofilaments. Brain Res. 637:1996;37-44.
26. Tetzlaff W., Bisby M. A. Neurofilament elongation into regenerating facial nerve axons. Neuroscience. 29:1989;659-666.
27. Tokuda T., Ikeda S., Yanagisawa N., Ihara Y., Glenner G. G. Re-examination of ex-boxers' brains using immunohistochemistry with antibodies to amyloid β-protein and tau protein. Acta Neuropath. 82:1991;280-285.
28. Vickers J. C., Costa M. The neurofilament triplet is present in distinct subpopulations of neurons in the central nervous system of the guinea pig. Neuroscience. 49:1992;273-278.
29. Vickers J. C., Riederer B. M., Marugg R. A., Buee-Scherrer V., Buee L., Delacourte A., Morrison J. H. Alterations in neurofilament protein immunoreactivity in human hippocampal neurons related to normal aging and Alzheimer's disease. Neuroscience. 62:1994;1-13.
30. Vickers J. C., Chin D., Edwards A-M., Sampson V., Harper C., Morrison J. H. Dystrophic neurite formation associated with age related β-amyloid deposition in the neocortex: Clues to the genesis of neurofibrillary pathology. Exp. Neurol. 141:1996;1-11.
31. Vickers J. C. A cellular mechanism for the neuronal changes underlying Alzheimer's disease. Neuroscience. 78:1997;629-639.
32. Wang D., Munoz D. G. Qualitative and quantitative differences in senile plaque dystrophic neurites of Alzheimer's disease and normal aged brain. J. Neuropathol. Exp. Neurol. 54:1995;584-586.
33. Yasuhara O., Kawamata T., Aimi Y., McGeer E., McGeer P. Two types of dystrophic neurites in senile plaques of Alzheimer disease and elderly non-demented. Neurosci. Lett. 171:1994;73-76.